Donepezil HCl IR Pellets Manufacturer in India

Donepezil HCl IR Pellets Manufacturer in India

Pharmaceutical-Grade Donepezil HCl IR Pellets for Immediate-Release Oral Formulations

Donepezil HCl IR Pellets are multiparticulate pharmaceutical formulations designed for immediate-release oral dosage applications. The active ingredient is Donepezil Hydrochloride, identified by CAS Number 120011-70-3, with molecular formula C₂₄H₃₀ClNO₃ and molecular weight 416.0 g/mol.

The SDP pellet product portfolio lists Donepezil HCl IR Pellets in 10% and 16% strengths, providing two defined active-loading options for pharmaceutical formulation development.

The immediate-release pellet format provides a multiparticulate platform for oral formulation development, including suitable capsule-filling applications. Final release performance depends on the pellet composition, active loading, particle characteristics and applicable finished-product specification.

Key Features

• Donepezil HCl immediate-release pharmaceutical pellets
• Available in 10% and 16% strengths
• Pharmaceutical-grade multiparticulate formulation
• Immediate-release formulation platform
• Suitable for oral dosage-form development
• Suitable for capsule-filling applications
• Defined active ingredient loading
• Product-specific quality parameters
• Formulation flexibility
• Suitable for bulk pharmaceutical requirements

Product Information

Donepezil Hydrochloride is the hydrochloride salt of Donepezil. PubChem identifies Donepezil Hydrochloride with CAS 120011-70-3, molecular formula C₂₄H₃₀ClNO₃, and molecular weight 416.0 g/mol.

Donepezil Hydrochloride Monohydrate is a distinct form with CAS 884740-09-4, molecular formula C₂₄H₃₂ClNO₄, and molecular weight 434.0 g/mol.

For the finished pellet product, the active-loading percentage should be distinguished from the purity assay of the raw material. The 10% and 16% values represent the specified pellet strengths listed for Donepezil HCl IR Pellets.

Available Strengths

• Donepezil HCl IR Pellets — 10%
• Donepezil HCl IR Pellets — 16%

Applications

Donepezil HCl IR Pellets can be considered for:

• Immediate-release oral formulation development
• Multiparticulate pharmaceutical formulations
• Capsule-filling applications
• Oral dosage-form development
• Pharmaceutical formulation development
• Commercial pharmaceutical manufacturing

Why Donepezil HCl IR Pellets from Swapnroop?

• Pharmaceutical-Grade Pellets: Designed for pharmaceutical formulation applications.
• 10% and 16% Strength Options: Provides flexibility in active ingredient loading.
• Immediate-Release Format: Designed for immediate-release multiparticulate applications.
• Multiparticulate Platform: Suitable for pellet-based oral dosage-form development.
• Product-Specific Quality Control: Finished pellets can be evaluated against applicable product specifications.
• Capsule-Filling Applications: Suitable for formulations using multiparticulate capsule filling.
• Bulk Pharmaceutical Supply: Suitable for formulation and manufacturing requirements.

Packaging & Supply

Donepezil HCl IR Pellets can be supplied in suitable bulk packaging according to customer requirements. Strength, batch quantity, packaging configuration and applicable technical documentation can be specified according to the intended pharmaceutical formulation.

Get Bulk Quote via WhatsApp